• Home
  • Events
  • COVID-19 Journal Club: Effectiveness of the BNT162b2 mRNA vaccine

COVID-19 Journal Club: Effectiveness of the BNT162b2 mRNA vaccine

Month Flat Week Day
  • Categories
  • Print
Date: Wednesday, March 24, 2021 3:00 pm - 4:00 pm
Categories: TraCS-sponsored

Join this month's journal club to discuss the use of real world data to evaluate the effectiveness of the BNT162b2 mRNA vaccine as described in this recent paper: BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting


Background

As mass vaccination campaigns against coronavirus disease 2019 (COVID-19) commence worldwide, vaccine effectiveness needs to be assessed for a range of outcomes across diverse populations in a noncontrolled setting. In this study, data from Israel's largest health care organization were used to evaluate the effectiveness of the BNT162b2 mRNA vaccine.


Discussion Leaders

Michele Jonsson-Funk, PhD and Sara Dejene


Register

Get NC TraCS events and news delivered to your inbox! Subscribe to our weekly email blast

Need help advertising your event? Contact Michelle Maclay at michelle_maclay@med.unc.edu

NC TraCS Institute logo vertical

In partnership with:

Contact Us

Brinkhous-Bullitt, 2nd floor
160 N. Medical Drive
Chapel Hill, NC 27599

919.966.6022
This email address is being protected from spambots. You need JavaScript enabled to view it.

Social

Cite Us

CitE and SUBMit CTSA Grant number - UM1TR004406

© 2008-2024 The North Carolina Translational and Clinical Sciences (NC TraCS) Institute at The University of North Carolina at Chapel Hill
The content of this website is solely the responsibility of the University of North Carolina at Chapel Hill and does not necessarily represent the official views of the NIH   accessibility | contact